TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹367 Cr | ₹281 Cr | ₹688 Cr | ₹544 Cr | ₹744 Cr |
What is the latest Capital Work in Progress ratio of TORRENT PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹281 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹544 Cr |
| Mar2021 | ₹744 Cr |
How is Capital Work in Progress of TORRENT PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | 30.79 | |
| Mar2024 | ₹281 Cr | -59.20 | |
| Mar2023 | ₹688 Cr | 26.44 | |
| Mar2022 | ₹544 Cr | -26.83 | |
| Mar2021 | ₹744 Cr | - | |
Compare Capital Work in Progress of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹150,410.3 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
| MANKIND PHARMA | ₹91,161.8 Cr | 1% | 6.6% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.2% |
9% |
44.8% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses